Treatment

Response to: ‘ANA testing in “real life”’ by Infantino et al
David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

Annals of the Rheumatic Diseases Nov 2018, annrheumdis-2018-214650; DOI: 10.1136/annrheumdis-2018-214650
Response to: ’Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist’ by Cherqaoui et al
Nadia Bonekamp, Roberta Caorsi, Joost Frenkel, Marco Gattorno

Annals of the Rheumatic Diseases Dec 2018, 77 (12) e89; DOI: 10.1136/annrheumdis-2017-212832
Response to: ‘Simultaneous inhibition of α4/β7 integrin and tumor necrosis factor-α in concomitant spondyloarthritis and inflammatory bowel disease’ by Richard et al
Gaëlle Varkas, Dirk Elewaut

Annals of the Rheumatic Diseases Dec 2018, 77 (12) e87; DOI: 10.1136/annrheumdis-2017-212858
Response to: ‘Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis’ by Chevreau et al
Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, Hilde Berner Hammer, Anna-Birgitte Aga, Désirée van der Heijde, Tore Kristian Kvien, Bjørg-Tilde Svanes Fevang, Siri Lillegraven, Espen Andre Haavardsholm

Annals of the Rheumatic Diseases Dec 2018, 77 (12) e85; DOI: 10.1136/annrheumdis-2017-212869
Therapeutic innovation in adult-onset Still’s disease (and other rare inflammatory disorders): how to secure evidence-based medicine?
Philippe Guilpain, Alain Le Quellec, Alexandre Thibault Jacques Maria

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1699-1701; DOI: 10.1136/annrheumdis-2018-213106
Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus
Julie Barsalou, Nathalie Costedoat-Chalumeau, Adey Berhanu, Cesar Fors-Nieves, Ummara Shah, Patrick Brown, Carl A Laskin, Nathalie Morel, Kateri Levesque, Jill P Buyon, Earl D Silverman, Peter M Izmirly

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1742-1749; DOI: 10.1136/annrheumdis-2018-213718
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
Nadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, Johannes W G Jacobs, Paco M J Welsing, Désirée van der Heijde, Daniel Aletaha, Maxime Dougados, Kimme L Hyrich, Iain B McInnes, Ulf Mueller-Ladner, Ladislav Senolt, Zoltan Szekanecz, Jacob M van Laar, György Nagy, On behalf of the whole EULAR Task Force on development of EULAR recommendations for the comprehensive management of difficult-to-treat rheumatoid arthritis

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1705-1709; DOI: 10.1136/annrheumdis-2018-213687
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications
Samuel Bitoun, Corinne Miceli-Richard, Céline Verstuyft, Pierre Antoine Juge, Philippe Dieudé, Jean-Marie Berthelot, Christophe Richez, Cécile Cauquil, Christelle Sordet, Sylvie Melac-Ducamp, Laure Gossec, Beatrice Bouvard, Emmanuelle Dernis, Eric Houvenagel, Marie-Astrid Boutry-Bacle, Xavier Mariette, Raphaèle Seror

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1835-1836; DOI: 10.1136/annrheumdis-2018-213183
Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, Wing-Yee Kwok, Dirk Elewaut, Tom W J Huizinga, Féline P B Kroon, Leonardo Punzi, Josef S Smolen, Bert Vander Cruyssen, Ron Wolterbeek, Gust Verbruggen, Ruth Wittoek

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1757-1764; DOI: 10.1136/annrheumdis-2018-213202
Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study
Richard James Partington, Sara Muller, Toby Helliwell, Christian D Mallen, Alyshah Abdul Sultan

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1750-1756; DOI: 10.1136/annrheumdis-2018-213883

Main menu

Treatment

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Treatment

Pages